This Week in IBD: Your Weekly Roundup for March 10-16, 2026
Welcome to This Week’s IBD Movement Roundup
Welcome back to our weekly digest of the latest IBD news, research, and stories from our community! This week, we published 5 impactful pieces covering groundbreaking treatment developments, critical diagnostic insights, and inspiring patient experiences. From promising new research on SKYRIZI’s effectiveness in Crohn’s disease to important findings about cancer surveillance, plus a heartwarming patient story about overcoming treatment fears, this week’s content offers both hope and practical insights for our IBD community.
News & Updates
This week brought significant developments in IBD research and treatment options:
AbbVie’s SKYRIZI Shows Promise for Crohn’s Disease: 55% Remission Rate Offers New Hope
AbbVie’s SKYRIZI achieves 55% remission rate in Crohn’s disease Phase 3 trial, offering new hope for difficult-to-treat patients with faster relief.
When Crohn’s Disease Masquerades as Another Condition: A Critical Lesson in Accurate Diagnosis
Critical case study reveals how Crohn’s disease can mimic other conditions, leading to misdiagnosis and life-threatening complications. Learn key diagnostic …
New Research Reveals Critical Differences in Cancer Risk from IBD-Related Precancerous Lesions
New IBD research reveals that precancerous colorectal lesion grades significantly impact cancer risk, offering hope for personalized surveillance strategies.
New Subcutaneous Infliximab Data Offers Hope for IBD Patients After Treatment Interruptions
New ECCO research shows subcutaneous infliximab effectively helps IBD patients regain remission after treatment interruptions, offering hope for better conti…
Patient Stories
We also shared an inspiring personal journey from our community:
From Needle Phobia to New Beginnings: My Journey Starting Biologic Treatment
College student overcomes needle phobia to start biologic treatment for Crohn’s Disease. A hopeful story about facing injection fears and finding effective I…
Thank You for Being Part of Our Community
Thank you for being such an important part of the IBD Movement community. We hope this week’s articles provide you with valuable insights, hope, and practical information for your IBD journey. Please take time to read the full articles that interest you most, and don’t hesitate to share them with others who might benefit from this information. Together, we’re building a stronger, more informed IBD community.
Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with your healthcare provider before making any changes to your treatment plan.